APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 77 filers reported holding APTOSE BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $924,512 | +48.9% | 1,444,550 | +34.9% | 0.03% | +40.9% |
Q4 2022 | $620,892 | +16.1% | 1,070,504 | +19.0% | 0.02% | +10.0% |
Q3 2022 | $535,000 | -14.4% | 899,554 | +6.8% | 0.02% | -9.1% |
Q2 2022 | $625,000 | -41.9% | 842,174 | +6.4% | 0.02% | -31.2% |
Q1 2022 | $1,076,000 | +40.5% | 791,274 | +39.5% | 0.03% | +52.4% |
Q4 2021 | $766,000 | -31.4% | 567,314 | +10.7% | 0.02% | -38.2% |
Q3 2021 | $1,117,000 | -11.5% | 512,519 | +34.9% | 0.03% | -10.5% |
Q2 2021 | $1,262,000 | -35.3% | 380,044 | +16.4% | 0.04% | -38.7% |
Q1 2021 | $1,950,000 | +53.3% | 326,390 | +12.4% | 0.06% | +44.2% |
Q4 2020 | $1,272,000 | -17.7% | 290,440 | +12.7% | 0.04% | -29.5% |
Q3 2020 | $1,546,000 | -1.2% | 257,665 | +4.0% | 0.06% | -11.6% |
Q2 2020 | $1,564,000 | +9.3% | 247,855 | +2.9% | 0.07% | -18.8% |
Q1 2020 | $1,431,000 | +6.4% | 240,965 | +1.6% | 0.08% | +49.1% |
Q4 2019 | $1,345,000 | +182.6% | 237,150 | +3.9% | 0.06% | +147.8% |
Q3 2019 | $476,000 | -16.8% | 228,150 | +4.1% | 0.02% | -20.7% |
Q2 2019 | $572,000 | – | 219,150 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 690,000 | $4,123,000 | 3.63% |
DRW Securities, LLC | 7,976,176 | $47,658,000 | 1.89% |
Ally Bridge Group (NY) LLC | 1,409,150 | $8,420,000 | 1.61% |
Nantahala Capital Management | 7,738,892 | $46,240,000 | 1.35% |
PRECEPT MANAGEMENT LLC | 330,766 | $1,976,000 | 1.35% |
First Light Asset Management, LLC | 3,102,788 | $18,539,000 | 1.23% |
Voss Capital, LLC | 440,000 | $2,629,000 | 1.10% |
VR Adviser, LLC | 1,605,400 | $9,592,000 | 1.04% |
Endurant Capital Management LP | 517,472 | $3,092,000 | 0.81% |
Opaleye Management Inc. | 871,800 | $5,209,000 | 0.76% |